Predictors of Poor Response After Primary Immunization of Hepatitis B Vaccines for Infants and Antibody Seroprotection of Booster in a Metropolis of China
Abstract:To evaluate proportion and predictors of poor response in infants and appraise booster seroprotection, we surveyed 2047 infants in Shanghai and detected antibody to hepatitis B (HB) surface antigen (anti-HBs). Poor responders were randomized into 2 groups, given booster with 5 µg and 10 µg hepatitis B vaccine (HepB), respectively. Proportion of infants with titer <10 mIU/mL and 10 to 99 mIU/mL was 1.86% and 15.14%, respectively. Multivariate logistic regression suggested infants of male, aged 13 to 18 months, … Show more
“…The rate of weak positive response is comparable to the study by Li et al ., despite a higher dose of HBV vaccine (10 vs. 5 μg) given in our study.…”
Section: Discussionsupporting
confidence: 89%
“…The Centers for Disease Control guidelines define the post‐vaccination anti‐HBs response as immune if the anti‐HBs titres are higher than 10 IU/L. However, there are studies by European and Chinese groups showing that infants born to chronic hepatitis B carrier mothers are also at risk of horizontal transmission from their mothers and family members. Hence, these infants should ideally achieve and maintain anti‐HBs titre greater than 100 IU/L.…”
Hepatitis B vaccine regimens using monovalent or combination vaccine for the third dose showed similarly high vaccine effectiveness and low immunoprophylaxis failure rate in term infants born to chronic hepatitis B carrier mothers.
“…The rate of weak positive response is comparable to the study by Li et al ., despite a higher dose of HBV vaccine (10 vs. 5 μg) given in our study.…”
Section: Discussionsupporting
confidence: 89%
“…The Centers for Disease Control guidelines define the post‐vaccination anti‐HBs response as immune if the anti‐HBs titres are higher than 10 IU/L. However, there are studies by European and Chinese groups showing that infants born to chronic hepatitis B carrier mothers are also at risk of horizontal transmission from their mothers and family members. Hence, these infants should ideally achieve and maintain anti‐HBs titre greater than 100 IU/L.…”
Hepatitis B vaccine regimens using monovalent or combination vaccine for the third dose showed similarly high vaccine effectiveness and low immunoprophylaxis failure rate in term infants born to chronic hepatitis B carrier mothers.
“…Sex is also a predictor of response and male infants are more likely to have an inferior response than female infants. 24,36 Various theories resulting from several studies found a decrease in the number of T lymphocytes in males compared to females, and men have lower serum IgM and IgG levels. The different immune response between male and female is also influenced by sex steroid hormones such as estrogen, progesterone, and testosterone, which are different in each sex.…”
Introduction: Hepatitis B virus (HBV) infection is a major global health issues and one of the most dangerous viral infections with a high mortality rate. Newborns and infant vaccination against chronic HBV infection are crucial for preventing mother-to-child transmission (MTCT). This study aimed to conduct a meta-analysis to investigate the factors affecting long-term protection against Hepatitis B Immunization in infancy. Material and Methods: Our literature searches are from PubMed, Science Direct, Web of Science, and ProQuest publications between January 2000 and December 2021. The included literature assessed the risk of bias using the Newcastle Ottawa Quality Assessment Scale. We identify Hepatitis B surface antibodies (anti-HBs) ≥ 10 mIU/mL as being protective against HBV infection. The results are combined with a random effect or fixed effect model. Results: Eighteen eligible observational studies with a total of 16,642 participants were included. Analysis of factors affecting long-term protection status by assessing anti-HBs titers showed significant results on several factors, including gestational age for anti-HBs titers (OR 2.5; 95% CI 1.62-3.85; p<0.0001), weight for age to anti-HBs titers (OR 1.36; 95% CI 1.06-1.75; p=0.02), length for age to anti-HBs titers (OR 0.01; 95% CI 0.01-0.02; p<0.00001), and immunization status based on the number of vaccine doses (4 doses vs 3 doses) to anti-HBs titers (p<0.00001). Conclusions: Anti-HBs titers of hepatitis B immunization were significantly affected by gestational age, weight for age, length for age, and vaccine doses. Parents of newborns must be informed about basic immunization and provide adequate nutritional intake to the mother and babies to prevent HBV infection.
“…4,[20][21][22][23][24] Farklı oranların gözlenmesinde ülkelerin HBV açısından endemisite statülerindeki, ilk aşılama yaşındaki, aşılama programları çizelgesindeki, aşı tipindeki (plazma bazlı ve rekombinant), uygulanan doz miktarındaki, doz sayısındaki ve uygulama yolundaki farklılıkların etkili olduğu düşünülmektedir. 1,4,25,26 İmmünsupresyon ve obezite gibi ek faktörlerin de hem anti-HBs reaktivite oranlarını hem de anti-HBs titre değerlerini etkileyebileceği bildirilmiştir. 1,4,20,27 Çalışmamızda, anti-HBs için reaktif ve nonreaktif olan gruplar arasında cinsiyet dağılımı açısından istatistiksel olarak anlamlı farklılık saptanmıştır.…”
Hepatit B virüsü (HBV), akut ve kronik hepatit etkenlerinin önde gelen nedenidir. 1 Yaklaşık olarak dünya nüfusunun 1/3'ünün daha önce HBV enfeksiyonu geçirdiği, 250 milyondan fazla kişinin de kronik olarak enfekte olduğu tahmin edilmektedir. 2 Ülkemiz HBV seroprevalansına (%2-4) göre orta düzeyde endemik bir ülkedir. 3
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.